These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 15294262)

  • 21. Atrial antifibrillatory effects of structurally distinct IKur blockers 3-[(dimethylamino)methyl]-6-methoxy-2-methyl-4-phenylisoquinolin-1(2H)-one and 2-phenyl-1,1-dipyridin-3-yl-2-pyrrolidin-1-yl-ethanol in dogs with underlying heart failure.
    Regan CP; Kiss L; Stump GL; McIntyre CJ; Beshore DC; Liverton NJ; Dinsmore CJ; Lynch JJ
    J Pharmacol Exp Ther; 2008 Jan; 324(1):322-30. PubMed ID: 17967939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
    Chiladakis JA; Kalogeropoulos A; Patsouras N; Manolis AS
    J Am Coll Cardiol; 2004 Aug; 44(4):859-63. PubMed ID: 15312872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardioversion of persistent atrial fibrillation by a combination of atrial specific and non-specific class III drugs in the goat.
    Blaauw Y; Schotten U; van Hunnik A; Neuberger HR; Allessie MA
    Cardiovasc Res; 2007 Jul; 75(1):89-98. PubMed ID: 17466958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiarrhythmic Effects of Combining Dofetilide and Ranolazine in a Model of Acutely Induced Atrial Fibrillation in Horses.
    Carstensen H; Kjær L; Haugaard MM; Flethøj M; Hesselkilde EZ; Kanters JK; Pehrson S; Buhl R; Jespersen T
    J Cardiovasc Pharmacol; 2018 Jan; 71(1):26-35. PubMed ID: 29068807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tachycardia-induced change of atrial refractory period in humans: rate dependency and effects of antiarrhythmic drugs.
    Yu WC; Chen SA; Lee SH; Tai CT; Feng AN; Kuo BI; Ding YA; Chang MS
    Circulation; 1998 Jun; 97(23):2331-7. PubMed ID: 9639377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rate- and site-dependent effects of propafenone, dofetilide, and the new I(Ks)-blocking agent chromanol 293b on individual muscle layers of the intact canine heart.
    Bauer A; Becker R; Freigang KD; Senges JC; Voss F; Hansen A; Müller M; Lang HJ; Gerlach U; Busch A; Kraft P; Kübler W; Schöls W
    Circulation; 1999 Nov; 100(21):2184-90. PubMed ID: 10571978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ranolazine effectively suppresses atrial fibrillation in the setting of heart failure.
    Burashnikov A; Di Diego JM; Barajas-Martínez H; Hu D; Cordeiro JM; Moise NS; Kornreich BG; Belardinelli L; Antzelevitch C
    Circ Heart Fail; 2014 Jul; 7(4):627-33. PubMed ID: 24874201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atrial effects of the novel K(+)-channel-blocker AVE0118 in anesthetized pigs.
    Wirth KJ; Paehler T; Rosenstein B; Knobloch K; Maier T; Frenzel J; Brendel J; Busch AE; Bleich M
    Cardiovasc Res; 2003 Nov; 60(2):298-306. PubMed ID: 14613859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KCB-328: a novel class III antiarrhythmic agent with little reverse frequency dependence in isolated guinea pig myocardium.
    Lee K; Lee JY; Kim HY; Kwon LS; Shin HS; Tanabe S; Kozono T; Park SD; Chung YS
    J Cardiovasc Pharmacol; 1998 Apr; 31(4):609-17. PubMed ID: 9554812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the class III antiarrhythmic drug dofetilide on ventricular monophasic action potential duration and QT interval dispersion in stable angina pectoris.
    Sedgwick ML; Rasmussen HS; Cobbe SM
    Am J Cardiol; 1992 Dec; 70(18):1432-7. PubMed ID: 1442614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of propafenone on resetting and termination of canine atrial flutter.
    Mensour B; Jalil E; Vinet A; Kus T
    Pacing Clin Electrophysiol; 2000 Aug; 23(8):1200-19. PubMed ID: 10962741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced ventricular proarrhythmic potential of the novel combined ion-channel blocker AZD1305 versus dofetilide in dogs with remodeled hearts.
    Johnson DM; de Jong MM; Crijns HJ; Carlsson LG; Volders PG
    Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):201-9. PubMed ID: 22080293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of intravenous ibutilide vs. propafenone for rapid termination of recent onset atrial fibrillation.
    Zhang N; Guo JH; Zhang HCh; Li XB; Zhang P; Xn Y
    Int J Clin Pract; 2005 Dec; 59(12):1395-400. PubMed ID: 16351670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the effects on drug concentrations, electrophysiologic parameters, and termination of atrial fibrillation in dogs when procainamide and ibutilide are delivered into the right atrium versus intravenously.
    Vereckei A; Warman E; Mehra R; Zipes DP
    J Cardiovasc Electrophysiol; 2001 Mar; 12(3):330-6. PubMed ID: 11291807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined use of 1C and III agents for highly symptomatic, refractory atrial fibrillation.
    Narayan G; Akhtar M; Sra J
    J Interv Card Electrophysiol; 2006 Apr; 15(3):175-8. PubMed ID: 16917731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrophysiological and antiarrhythmic effects of the novel I(Kur) channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I(Kr) blockers dofetilide, azimilide, d,l-sotalol and ibutilide.
    Knobloch K; Brendel J; Peukert S; Rosenstein B; Busch AE; Wirth KJ
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):482-7. PubMed ID: 12382079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pro- and antiarrhythmic effects of fast cardiac pacing in a canine model of acquired long QT syndrome.
    Bauer A; Donahue JK; Voss F; Becker R; Kraft P; Senges JC; Kelemen K; Katus HA; Schoels W
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Apr; 369(4):447-54. PubMed ID: 14985939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of the ion channel-blocking profile of the novel combined ion channel blocker AZD1305 and its proarrhythmic potential versus dofetilide in the methoxamine-sensitized rabbit in vivo.
    Carlsson L; Andersson B; Linhardt G; Löfberg L
    J Cardiovasc Pharmacol; 2009 Jul; 54(1):82-9. PubMed ID: 19528812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrophysiologic effects of the new class III antiarrhythmic drug dofetilide compared to the class IA antiarrhythmic drug quinidine in experimental canine atrial flutter: role of dispersion of refractoriness in antiarrhythmic efficacy.
    Cha Y; Wales A; Wolf P; Shahrokni S; Sawhney N; Feld GK
    J Cardiovasc Electrophysiol; 1996 Sep; 7(9):809-27. PubMed ID: 8884510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial-selective sodium channel block as a strategy for suppression of atrial fibrillation.
    Burashnikov A; Di Diego JM; Zygmunt AC; Belardinelli L; Antzelevitch C
    Ann N Y Acad Sci; 2008 Mar; 1123():105-12. PubMed ID: 18375582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.